Search Ontology:
ChEBI
erythromycin B
- Term ID
- CHEBI:28196
- Synonyms
-
- (3R,4S,5S,6R,7R,9R,11R,12S,13R,14R)-4-(2,6-dideoxy-3-C-methyl-3-O-methyl-alpha-L-ribo-hexopyranosyloxy)-14-ethyl-7,12-dihydroxy-6-[3,4,6-trideoxy-3-(dimethylamino)-beta-D-xylo-hexopyranosyloxy]-3,5,7,9,11,13-hexamethyloxacyclotetradecane-2,10-dione
- 12-deoxyerythromycin
- beritromicina
- Berythromycin
- berythromycine
- berythromycinum
- Erythromycin B
- Definition
- An erythromycin that consists of erythronolide B having 2,6-dideoxy-3-C-methyl-3-O-methyl-α-L-ribo-hexopyranosyl and 3,4,6-trideoxy-3-(dimethylamino)-β-D-xylo-hexopyranosyl residues attahced at positions 4 and 6 respectively.
- References
-
- beilstein:5206722
- cas:527-75-3
- kegg.compound:C06653
- kegg.drug:D03098
- lipidmaps:LMPK04000012
- metacyc.compound:CPD-13805
- patent:CN101104631
- pubmed:10669574
- pubmed:20381987
- pubmed:21175699
- reaxys:74652
- Ontology
- ChEBI ( EBI )
- Resources
- CTD
Phenotype
Phenotype resulting from erythromycin B
Phenotype where environments contain erythromycin B
Phenotype modified by environments containing erythromycin B
Phenotype affecting erythromycin B
Human Disease Model